SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055947
Filing Date
2021-11-10
Accepted
2021-11-10 08:13:20
Documents
56
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cogt-10q_20210930.htm   iXBRL 10-Q 1915374
2 EX-31.1 cogt-ex311_9.htm EX-31.1 9996
3 EX-31.2 cogt-ex312_8.htm EX-31.2 9969
4 EX-32.1 cogt-ex321_7.htm EX-32.1 5979
5 EX-32.2 cogt-ex322_6.htm EX-32.2 5944
  Complete submission text file 0001564590-21-055947.txt   6294884

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cogt-20210930.xsd EX-101.SCH 47319
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cogt-20210930_cal.xml EX-101.CAL 45302
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cogt-20210930_def.xml EX-101.DEF 180932
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20210930_lab.xml EX-101.LAB 373215
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20210930_pre.xml EX-101.PRE 284449
11 EXTRACTED XBRL INSTANCE DOCUMENT cogt-10q_20210930_htm.xml XML 893648
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 211394531
SIC: 2834 Pharmaceutical Preparations